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Introduction 
Coagulase-negative staphylococci (CoNS), particularly 
Staphylococcus epidermidis, are among the most frequently 
isolated microorganisms in clinical microbiology labora- 
tories. The vast majority of infections assumed to be 
caused by CoNS comprise a significant consequence of 
hospitalization [l]. Reports on surveillance data taken 
from the National Nosocomial Infections Surveillance 
System during the late 1980s and early 1990s have 
indicated that CoNS are among the five most com- 
monly reported pathogens in hospitals conducting 
hospital-wide surveillance. In addition, CoNS were the 
most frequently reported pathogens in nosocomial 
bloodstream infections [2,3]. 
One of the major problems facing the laboratory is 
dstinguishing clinically significant, pathogenic strains 
of CoNS from contaminant strains because of their 
prevalence on human skin and mucous membranes 
and their relatively low virulence. Currently, out of 
more than 30 coagulase-negative species, 12 species are 
mainly found in specimens of human origin [1,4]. 
In clinical microbiology it is very important to 
differentiate CoNS on the basis of their novobiocin 
susceptibility. The most important group of the novo- 
biocin-susceptible CoNS comprises five species and 
is designated the S. epidermidis group. Within this 
group, S. epidermidis sensu strict0 is the most commonly 
isolated species, followed by S. huemolyticus and S. 
hominis [1,4]. 
Several possible virulence factors have been 
described for strains of novobiocin-susceptible CoNS, 
especially S. epidermidis. For example, some products of 
S. epiderrnidis, particularly peptidoglycan, induce the 
release of tumor necrosis factor-a, interleukin-1 p and 
interleukin-6 by human monocytes [5,6]. The quantity 
of tumor necrosis factor-a that is released depends 
particularly on the size of the peptidoglycan molecule, 
as well as the presence of human serum. In addition, at 
least some coagulase-negative staphylococcal strains 
express a specific receptor for human transferrin, based 
on a common cell wall protein with a molecular mass 
of 42 kDa [7f. The increasing importance of CoNS 
may be in part due to the growing appreciation of this 
group of organisms as opportunistic pathogens and to 
reports describing new virulence factors. Furthermore, 
CoNS have become the leading causative agent of 
hospital-acquired infections, particularly as the patient 
population changes. 
Groups of patients particularly susceptible to infections due 
to Staphylococcus epiderrnidis 
Several groups of patients are especially susceptible 
to S. epidermidis infections; in these patients, either 
S. epidevmidis or other coagulase-negative, novobiocin- 
susceptible staphylococcal species may be the pre- 
dominant cause of the infectious disease. 
On(: group comprises intravenous drug users, 
particularly heroin users, who frequently develop right- 
sided endocarditis, with s. epidermidis being the most 
frequently isolated causative organism. It has been 
postulated that heroin is injected intravenously in the 
form of microcrystals and causes microlesions of the 
tricuspid valvular endothelium. Repeated episodes of 
S. epidermidis bacteremia with large inocula, as a result 
of non-sterile injections, could then lead to tricuspid 
valve endocarditis [4]. However, these hypotheses have 
not yet been finally confirmed by experimental studies. 
The second group, which is increasing in numbers, 
consists of immunocompromised patients. In premature 
newborns the opsonophagocytosis system is still not 
adequately developed and is thus unable to handle peri- 
or postpartum infectious challenges, including those of 
pathogens with relatively low virulence, particularly 
bacteria such as the CoNS. S. epidermidis is the leading 
cause of septicemia in premature newborns if the onset 
occurs later than 24-48 h after birth [8]. Patients with 
neutropenia after cytostatic and/or immunosuppressive 
therapy are also susceptible to septicemia caused by S. 
epidermid’is. Most of these patients suffer Gom leukemia, 
but patients with other malignant diseases may also be 
at risk if the number of functioning granulocytes is too 
low [1,4). The main sources of infection are the skin 
and mucous membranes of the oral cavity, nose and 
urogenital tract, and the point of entry is very often an 
intravasciular catheter [ 1,9]. 
The most important group of particularly sus- 
ceptible patients are those with indwelling or implanted 
foreign polymer bodies. These devices are increasingly 
used-permanently or transiently-in diagnostic and 
therapeutic procedures. The most important compli- 
cation associated with the presence of foreign bodies 
is infection, and the most frequently isolated bacteria 
are CoNS, particularly S. epidermidis [9,10]. A battery 
of virulence factors involved in the pathogenesis of 
polymer-associated staphylococcal infection has been 
defined and characterized in recent years (see below). 
Furthermore, there is growing evidence that some 
other, more chronic associated clinical syndromes may 
also be at least partly associated with S. epidermidis. 
These ‘chronic polymer-associated syndromes’ with 
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possible involvement of S. epidermidis are the ‘aseptic’ 
loosening of hip prostheses or other joint prostheses 
[l 11, the fibrous capsular contracture syndrome after 
mammary augmentation with silicone prostheses [ 121, 
and the late-onset endophthalmitis after implantation 
of artificial intraocular lenses following cataract surgery 
[ 13). In different studies, identical clones, characterized 
by molecular typing methods, have been isolated at 
different times and/or from various multiple sites. 
Thus, in the cutaneous ecosystem, CONS generally 
function as commensal or saprophytic organisms. How- 
ever, if the barrier function of the skin is impaired by 
any trauma or during surgery, especially in association 
with the insertion or implantation of a foreign body, 
these organisms can gain entry to the host. Depending 
upon their ability to adhere to host or foreign body 
surfaces, breach or avoid the host immune system, 
multiply, and produce an inflammatory response in the 
host, they may then develop the lifestyle of a pathogen 
[I]. 
N e w  aspects of the pathogenesis of polymer-associated 
infections due to Staphylococcus epidermidis 
Most important in the pathogenesis of S. epidermidis 
infection associated with foreign bodies such as ortho- 
pedic devices, intravascular catheters, cerebrospinal fluid 
shunts, prosthetic heart valves, continuous ambulatory 
peritoneal dialysis (CAPD) catheters and cardiac pace- 
makers [lo] is the colonization of the polymer surface 
by formation of a biofilm. Such biofilms are composed 
of multilayered cell clusters embedded in an extra- 
cellular slime substance (ESS), which consists mainly of 
cell wall teichoic acids and host products [lo]. Biofilm 
formation proceeds in two steps: rapid adherence of 
S.  epidermidis cells to the polymer surface is followed by 
a more prolonged accumulation phase involving cell 
proliferation and intercellular adhesion. Adherence 
to biomaterials depends on the characteristics of the 
bacterial cell surface and on the nature of the polymer 
material and is influenced by non-specific physico- 
chemical forces such as polarity, van der WaalS forces 
and hydrophobic interactions [ 101. Initial adherence 
and cell surface hydrophobicity have been associated 
with bacterial surface proteins [14]. The staphylococcal 
surface proteins SSP-1 and SSP-2 are organized as 
fimbria-like polymers and have been described as 
mediating S. epidermidis adherence t o  polystyrene [15]. 
Recently, the surface-associated autolysin AtlE of S. 
epidermidis has been found to contribute to primary 
attachment of bacterial cells to a polymer surface [16]. 
Implanted material rapidly becomes coated with plasma 
and connective tissue proteins such as fibronectin, 
fibrinogen, and vitronectin [17,18] and some of 
these host factors could serve as specific receptors for 
colonizing bacteria [19,20]. The autolysin AtlE also has 
vitronectin-binding activity, suggesting not only a 
function in the early stages of adherence involving 
direct interactions between bacteria and naked polymer 
surfaces, but also a contribution to later stages of 
adherence involving specific interactions with vitro- 
nectin deposited on the polymer surface [16]. Aside 
from proteins, a polysaccharide structure, capsular 
polysaccharide/adhesin (PYA), has been attributed to 
cellular adherence to biomaterials [21]. 
Following the primary attachment to the polymer 
surface, the bacteria multiply and form multilayered cell 
clusters, which process requires intercellular adhesion. 
Recently, the specific polysaccharide intercellular anti- 
gen (PIA) involved in intercellular adhesion and biofilm 
accumulation has been detected. Purification and 
structural analysis of PIA revealed that it is a linear p- 
1,6-1inked glucosaminoglycan mainly composed of at 
least 130 2-deoxy-2-amino-D-glucopyranosyl residues, 
of which 8 0 4 5 %  are N-acetylated [22]. Most recently, 
the genes (icaABC) mediating cell clustering and 
PIA synthesis in S. epidermidis have been cloned 
and sequenced [23]. Moreover, additional factors are 
obviously essential for accumulative growth of S.  
epidermidis, such as the 140-kDa extracellular protein 
AAP (accumulation-associated protein), which is absent 
in an accumulation-negative but PIA-positive mutant 
[24]. How this antigen acts in accumulation has still to 
be explored. There is substantial evidence that biofilm- 
encased S. epidermidir is protected against host response 
mechanisms such as opsonophagocytosis and against 
antibiotic action [25]. This could explain the facts that 
even an immunocompetent host cannot eliminate the 
infectious focus on the foreign body and that antibiotic 
therapy also fails in most cases. 
Emergence of glycopeptide-resistant strains 
A large proportion of nosocomial isolates of CoNS 
are resistant to multiple antibiotics, including penicil- 
linase-resistant penicillins [26]. Given the extremely 
high frequency of these isolates, vancomycin has 
been recommended empirically for the treatment of 
infections produced by these microorganisms. Until 
recently, CoNS have displayed uniform susceptibility 
to glycopeptides. However, the emergence of strains 
with decreased levels of susceptibility to vancomycin 
and especially teicoplanin has been reported in several 
studies [27,28]. One study revealed that 14 of 32 
clinical isolates of CoNS exhibiting either decreased 
levels of susceptibility or true resistance to teicoplanin 
belonged to the species S. epidermidis [29]. The in vivo 
development of resistance to glycopeptides among 
CoNS strains limits the therapy of infections by these 
microorganisms. Thus, there is  a need for resistance 
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surveillance of nosocomial isolates of CONS, especially 
of the clinically increasing significant species S. 
epidermidis. 
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